3 days ago · We are developing a CGM system that is not only highly accurate but also disruptively affordable and user-friendly,” said John Gillard, CEO of Trinity Biotech. “The two …

3 days ago · Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Ireland, Jan. 28, 2025 (GLOBE …

Trinity Biotech management team in developing a disruptive technology for CGM and the broader biosensor and analytics markets. We believe that Trinity Biotech’s plans, coupled with the …

3 days ago · Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029. DUBLIN, Ireland, Jan. 28, 2025 (GLOBE …

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

3 days ago · Trinity Biotech's CGM system features significant improvements in signal quality, reliability, and a 25-30% enhancement in accuracy. How many participants were involved in …

3 days ago · Trinity Biotech's patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029. DUBLIN, Ireland, Jan. 28, 2025 (GLOBE …

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced it has entered into a definitive agreement to acquire the …

Oct 7, 2024 · Trinity Biotech implemented a research and development plan aimed at improving both the performance and usability of the CE-marked, 15-day wear CGM device. Key design …

3 days ago · This news is based on a press release statement from Trinity Biotech plc. In other recent news, Trinity Biotech reported a 3% year-on-year revenue growth in its third quarter of …